Rotavirus vaccines continue to reduce diarrhea hospitalizations, medical costs in US kids

August 10, 2017

Following the introduction of routine childhood vaccination against rotavirus, a common cause of diarrheal illness, more than 380,000 children avoided hospitalization for diarrhea from 2008 to 2013 in the U.S., thus saving an estimated $1.2 billion in direct medical costs. The estimates, from a new study published in the Journal of the Pediatric Infectious Diseases Society, provide additional evidence for the substantial impact of routine rotavirus vaccination. They also suggest even greater benefits from immunization if other avoided costs were to be considered.

For the study, researchers analyzed data from community and academic hospitals in 26 states, focusing on hospitalizations for acute gastroenteritis among children under 5 years old, to estimate the impact of rotavirus vaccination nationwide. They compared periods before and after vaccination licensure in 2006, excluding the first year during which vaccine coverage rates were low and uneven. Following the start of routine rotavirus vaccination in 2006, diarrhea hospitalizations decreased by between 31 percent to 55 percent from 2008 to 2013, with greater reductions in the later years. The researchers estimated that more than 380,000 hospitalizations for severe diarrhea in children younger than 5 were avoided across the U.S. during this six-year period.

"Our findings confirm the sustained impact and effectiveness of the rotavirus vaccine program," said author Eyal Leshem, MD, formerly of the Centers for Disease Control and Prevention (CDC) at the time of the study and who is currently affiliated with the Sackler Faculty of Medicine at Tel-Aviv University in Israel. "Increasing vaccine coverage likely resulted in the larger declines of rotavirus hospitalizations observed in the later years studied."

The researchers estimated that the direct medical cost savings from avoided hospitalizations for diarrhea in infants and young children were $1.2 billion nationwide during the 2008-2013 period. This amount likely underestimates the overall economic impact, the study authors noted, because other , such as those associated with averted doctor's office or emergency room visits for rotavirus disease, were not included in their analysis.

In 2015, an estimated 73 percent of U.S. children 19-35 months old received rotavirus vaccines, lower than rates for other routine childhood vaccines, including the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine, which 95 percent of the children in this same age group received, according to CDC. Future research should explore the reasons behind the lower than optimal rotavirus immunization rates and interventions to improve them, Dr. Leshem said. "Efforts to further increase rotavirus coverage rates to better protect all children in the U.S. against rotavirus disease should continue."

Fast Facts

  • Rotavirus is a common cause of in infants and young children in the United States.
  • Diarrhea hospitalizations in U.S. under 5 decreased by between 31 percent and 55 percent from 2008 to 2013, following the start of routine rotavirus vaccination in 2006.
  • Researchers estimated that more than 380,000 hospitalizations were averted nationwide during this six-year period, saving an estimated $1.2 billion in direct medical costs.

Explore further: Rotavirus vaccine greatly reduced gastroenteritis hospitalizations in children

More information: Eyal Leshem et al, National Estimates of Reductions in Acute Gastroenteritis–Related Hospitalizations and Associated Costs in US Children After Implementation of Rotavirus Vaccines, Journal of the Pediatric Infectious Diseases Society (2017). DOI: 10.1093/jpids/pix057

Related Stories

Rotavirus vaccine greatly reduced gastroenteritis hospitalizations in children

June 24, 2011
Vaccination against rotavirus, a major cause of severe acute gastroenteritis in children, dramatically decreased hospitalization rates for the infection among infants in three U.S. counties, according to a new study published ...

Examination of gastroenteritis hospitalization rates following use of rotavirus vaccine

June 9, 2015
Following implementation of rotavirus vaccination in 2006, all-cause acute gastroenteritis hospitalization rates among U.S. children younger than 5 years of age declined by 31 percent - 55 percent in each of the post-vaccine ...

Rotavirus vaccination leads to large decreases in health care costs, doctor visits

September 22, 2011
(Medical Xpress) -- Vaccinating infants against rotavirus has resulted in dramatic decreases in health care use and treatment costs for diarrhea-related illness in U.S. infants and young children, according to a new study ...

Vaccine for infant tummy bug cuts hospitalizations: CDC

June 9, 2014
(HealthDay)—Since the introduction of rotavirus vaccine in 2006, the number of kids hospitalized for severe diarrhea has dropped dramatically, a new study finds.

Ontario rotavirus hospitalizations drop 71 percent after launch of infant vaccine program

May 11, 2016
Immunizing babies against rotavirus in Ontario led to a 71% drop in hospitalizations for the infection, new research from Public Health Ontario (PHO) and the Institute for Clinical Evaluative Sciences (ICES) has shown.

Rotavirus vaccination of infants also protects unvaccinated older children and adults

August 30, 2011
Vaccinating infants against rotavirus also prevents serious disease in unvaccinated older children and adults, according to a study by the Centers for Disease Control and Prevention (CDC). This helps reduce rotavirus-related ...

Recommended for you

New cellular approach found to control progression of chronic kidney disease

December 15, 2017
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage ...

Testing shows differences in efficacy of Zika vaccines after one year

December 15, 2017
(Medical Xpress)—A large team of researchers with members from Harvard Medical School, Walter Reed Army Institute of Research, Bioqual Inc. and MIT has found that the efficacy of the three types of Zika vaccines currently ...

How to regulate fecal microbiota transplants

December 15, 2017
(Medical Xpress)—A small team of researchers at the University of Maryland, some with affiliations to the Veterans Affairs Maryland Health Care System, has written and published a Policy Forum piece in the journal Science ...

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

Aging impairs innate immune response to flu

December 13, 2017
Aging impairs the immune system's response to the flu virus in multiple ways, weakening resistance in older adults, according to a Yale study. The research reveals why older people are at increased risk of illness and death ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.